Supernus Pharmaceuticals (SUPN)

Add to Watchlists Create an Alert
6.47 -0.13  -1.97%   NASDAQ May 23, 2:16PM BATS Real time Currency in USD

Supernus Pharmaceuticals Revenue Quarterly YoY Growth:

2493% for Dec. 31, 2012
View Full Chart

Supernus Pharmaceuticals Revenue Quarterly YoY Growth Chart

    Supernus Pharmaceuticals Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 2493%
    Sept. 30, 2012 727.3%
       
    June 30, 2012 -87.87%

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    SUPN Revenue Quarterly YoY Growth Benchmarks

    Companies
    Pernix Therapeutics -14.98%
    Catalyst Pharmaceutical Partners
    Lannett Company 31.84%

    SUPN Revenue Quarterly YoY Growth Rankings

    Overall 99th percentile
    15 of 8006
    Sector 99th percentile
    5 of 686 in Healthcare
    Industry 97th percentile
    2 of 68 in Drug Manufacturers - Specialty & Generic

    SUPN Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -87.87% Jun 2012
    Maximum 2493% Dec 2012
    Average 1044%